Today: 21 July 2026
Browse Category

NYSE:MRK 12 November 2025 - 4 December 2025

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

As of the close on December 4, 2025, Merck & Co., Inc. shares finished at $100.86, down about 1.4% on the day, with after‑hours trading essentially flat around $100.83. The stock sits near the upper end of its 52‑week range of $73.31–$105.84, with a market value of roughly $250 billion, a trailing P/E around 13.3 and a forward P/E just under 12.MarketBeat+3StockAnalysis+3StockAnalysis+3
4 December 2025
··
Dow Jones Soars 664 Points as Fed Cut Hopes Ignite Dow 30 Rally — Merck and Home Depot Lead November 25, 2025 Surge

Dow Jones Soars 664 Points as Fed Cut Hopes Ignite Dow 30 Rally — Merck and Home Depot Lead November 25, 2025 Surge

The Dow Jones Industrial Average roared higher on Tuesday, November 25, 2025, with the Dow 30 jumping 664.18 points, or 1.43%, to 47,112.45, as investors doubled down on expectations that the Federal Reserve will cut interest rates at its December meeting. The S&P 500 added 0.91% to 6,765.88, while the tech‑heavy Nasdaq Composite gained 0.67% to 23,025.59. Small caps outperformed, with the Russell 2000 up about 2.1%. MarketScreener+2San Mateo Daily Journal+2
25 November 2025
···
Dow 30 Today (24 November 2025): Merck and Caterpillar Lead 200‑Point Dow Jones Rally on Fed Rate‑Cut Bets

Dow 30 Today (24 November 2025): Merck and Caterpillar Lead 200‑Point Dow Jones Rally on Fed Rate‑Cut Bets

On Monday, 24 November 2025, the Dow Jones Industrial Average climbed 202.86 points, or 0.44%, to 46,448.27, kicking off the holiday‑shortened week with a strong risk‑on tone. The rally was powered by healthcare and industrial heavyweights such as Merck, Caterpillar, IBM and Nvidia, while tech‑driven enthusiasm sent the Nasdaq up 2.69% and the S&P 500 up 1.55%. Reuters+2Reuters+2
25 November 2025
·········
Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck (MRK) Jumps as Oral PCSK9 Data Power Momentum; New Keytruda Diagnostic Cleared — What’s Moving the Stock Today (Nov. 12, 2025)

Merck & Co., Inc. extended this week’s rally on Wednesday as investors digested fresh late‑stage results for its investigational oral PCSK9 inhibitor and an FDA clearance that supports broader precision use of Keytruda-based therapy. Below is what changed today and how it fits into Merck’s 2025 storyline.
12 November 2025
··
1 … 5 6 7 8
Go toTop